
|Articles|December 2, 2004
AMO buys VISX
The unexpected move by Advanced Medical Optics Inc. (AMO) to acquire VISX Inc. in a $1.27 billion cash and stock deal caught Wall Street-and many in the ophthalmic industry-by complete surprise.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
3
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
4
Inner plexiform layer substrata: Possible biomarker of retinal health
5



























